Clinical course of optic neuritis in patients with relapsing neuromyelitis optica

Archives of Ophthalmology

Volumn 126, Issue 1, 2008, Pages 12-16

  Papais Alvarenga, Regina Maria ^a,b   Carellos, Sandro Carvalho ^b   Alvarenga, Marcos Papais ^b   Holander, Clarice ^a   Bichara, Roberly Pinto ^a   Thuler, Luiz Claudio Santos ^b,c  

^a HOSPITAL DA LAGOA   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE; VISUAL IMPAIRMENT;

ADULT; BRAZIL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; OPTIC NEURITIS; PROGNOSIS; RECURRENCE; VISION DISORDERS;

EID: 38349057576     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archophthalmol.2007.26     Document Type: Article

References (25)

1. Devic E. Myelite subaigue compliquee de neurite optique. Bull Med. 1894;8:1033-1034.
2. Miyazawa I, Fujihara K, Itoyama Y. Eugene Devic (1858-1930). J Neurol. 2002;249(3):351-352.
3. Kantarci OH, Weinshenker B. Natural history of multiple sclerosis. Neurol Clin. 2005;23(1):17-38.
4. O'Riordan JI, Gallagher L, Thompson AJ, Howard RS, Milleret DH. Clinical, CSF and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996;60(4):382-387.
5. Wingerchuk DM, Hogancamp WF, O'Brien PC, Peter C, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
6. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002;73(4):429-435.
7. de Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002;197(1-2):57-61.
8. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol. 2004;251(1):47-52.
9. Lucchinetti CF, Mandler RN, Mcgavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(Pt 7):1450-1461.
10. Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol. 2004;149(1-2):182-186.
11. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of opticspinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473-477.
12. Alvarenga RMP. SIAPEM. Af J Neurological Sciences. 2003;22(2):10-20.
13. Vaughan D. Oftalmologia Geral. 15th ed. São Paulo, Brazil: Atheneu; 2003:15.
14. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1991;41(5):657-660.
15. Horton JC. Visual disturbances. In: Hauser SL, Kasper DL, Braunwald E, Fauci AS, Longo DL, eds. Harrison's Neurology in Clinical Medicine. New York, NY: McGraw-Hill Professional; 2006:140-141.
16. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol. 1991;109(12):1673-1678.
17. Phillips PH, Newman NJ, Lynn MJ. Optic neuritis in African Americans. Arch Neurol. 1998;55(2):186-192.
18. Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG. The natural history of recurrent optic neuritis. Arch Neurol. 2004;61(9):1401-1405.
19. Agostoni E, Frigerio R, Protti A. Controversies in optic neuritis pain diagnosis. Neurol Sci. 2005;26(suppl 2):s75-s78.
20. Volpe NJ. Optic neuritis: historical aspect. J Neuroophthalmol. 2001;21(4):302-309.
21. Papais-Alvarenga RM, Correa JA, Mattielo M, Santos CMM, Puccioni-Sohler M, Alvarenga H. Neuromyelitis optica-NMO (Devic's syndrome): application of the Mayo Clinic criteria for NMO to the ethnically diverse population of Brazil. In: Columbus F, ed. Treatment and Management of Multiple Sclerosis. New York, NY: Nova Publishers; 2005:273-288.
22. Wingerchuk DM, Lennon VA, Pittock SJ, Luchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
23. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003;2(2):117-126.
24. Cree BAC, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol. 2002;22(2):105-122.
25. Papais-Alvarenga RM, Alves-Leon SV, Miranda Santos CM, Tilbery CP. South Atlantic project: a Brazilian multiple sclerosis trial. In: Arriagada RC, Nogales-Gaete J, eds. Esclerosis Múltiple - una Mirada Ibero Pan Americana. Santiago, Chile: Arrynog Ediciones; 2002:35-45.